Open-label Extension Study in Paediatric Patients Who Have Completed the MEX-NM-301 Study.

Summary

Open-label Extension Study to Evaluate the Long-term Safety and Efficacy of Mexiletine in Paediatric Patients with Myotonic Disorders Who Have Completed the MEX-NM-301 study.

Timeline

Start

2021-11-05

Primary completion

2026-01-26

Completion

2026-03-12

Drugs

Indications